Malignant Intestinal Neoplasm — Trials

Malignant Intestinal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,768 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,665
Recruiting: 938
Ph III recruiting: 109
Growth YoY: +14.4%
Industry share: 21%
Top sponsor: Fudan University
Termination share: 25.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (772)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04100694	Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor	approved for marketing	—	—	Merus B.V.INDUSTRY	0	May 20, 2025	clinicaltrials
NCT03906331	Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation	approved for marketing	—	—	Eli Lilly and CompanyINDUSTRY	13	Jan 17, 2025